Characteristics of Participation in Patient-Reported Outcomes and Electronic Data Capture Components of NRG Oncology Clinical Trials.

ABSTRACT:

Purpose

To assess the reasons why patients do not consent to patient-reported outcome (PRO) and electronic PRO data capture components of clinical trials and potential selection bias by having a separate consent.

Methods and materials

Selected NRG Oncology trials were included based on disease site and inclusion of PROs and electronic PRO data capture via VisionTree Optimal Care as separate consent questions. Reasons for not participating were assessed. Pretreatment characteristics between patients who did and did not consent were tested using χ² and t tests for univariate comparisons and logistic regression for multivariable analyses.

Results

Ten trials were selected in head and neck, prostate, gynecologic, breast, lung, and gastrointestinal cancers, with

SUBMITTER: Pugh SL 

PROVIDER: S-EPMC7572717 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature